cp101
Cell therapyexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started May 1, 2018 (NCT03497806)
Timeline
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05153499 | Phase 3 | Nov 15, 2021 | Finch Research and Development LLC. |
| NCT03829878 | Phase 2 | May 31, 2020 | Finch Research and Development LLC. |
| NCT03497806 | Phase 2 | May 1, 2018 | Finch Research and Development LLC., Medpace, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Finch Research and Development LLC. | For profit | 3 | 3 | 2 | 2018 |
| Medpace, Inc. | For profit | 1 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1